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Adrenocortical function was assessed on the basis of changes in salivary cortisol in patients with
pulmonary tuberculosis and the findings compared with those in healthy subjects. A method of direct
radioimmunoassay of salivary cortisol was standardized and the sensitivity was 0.8 nmol/l. Cortisol
levels in saliva were significantly higher in the patients than in the healthy subjects (P < 0.001). The
diurnal rhythm of cortisol secretion was disturbed in the patients with a significant increase in salivary
cortisol beyond 1800 h. While dexamethasone caused an appreciable suppression (87%), stimulation with
ACTH (tetracosactrin) resulted in a marked increase in salivary cortisol, the increase being significantly
higher in the healthy subjects than in the patients (P < 0.001). Attempts to classify subjects as positive or
negative responders to tetracosactrin based on increases in salivary cortisol in relation to ‘plasma
cortisol changes were however not successful, as the agreement between the two methods ranged from 73
to 80 per cent with various criteria used.
Salivary cortisol is believed to be a better
measure of assessing adrenocortical function than
plasma cortisol as it reflects the biologically active
‘free’ fraction (more than 90% of circulating
cortisol is bound to plasma proteins, particularly
the glycoprotein; transcortin)1-6. Most radio-
immunoassay (RIA) methods described for the
determination of salivary cortisol concentrations
employ ‘in house’ reagents (antisera and labelled
antigens). Al-Ansari et a17 have described a
procedure adapting a commercial serum cortisol
immunophase kit for assays in saliva. We followed
with some modifications this procedure for use of
the ‘Amerlex’ kits (Amersham, UK) supplied for
cortisol assays in serum/plasma, for the determi-
nation of cortisol levels in saliva.
Tuberculosis has traditionally been believed to
be o e of the causes of adrenal insufficiency in
man8. Data on the adrenocortical function based
o  plasma cortisol in these patients is limited9-11,
while no data is available based on salivary
cortisol. We recently undertook an investigation
to study the adrenocortical function in patients
with pulmonary tuberculosis employing the
ACTH (tetracosactrin) stimulation and dexame-
thasone suppression tests, and a study of the
diurnal variation of cortisol release, and the
findings were compared with those in healthy
ubjects. Matched samples of blood and saliva
were collected during this investigation; we have
reported our findings based on plasma levels12,
and we present in this report those based on
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salivary cortisol together with the details of the
procedure for assay of cortisol in saliva.
Material & Methods
Collection of saliva : Salivary gland secretion was
stimulated by masticating a piece of unflavoured,
unsweetened chewing gum. The collected saliva
was frozen (kept at –20°C overnight); then thawed
and centrifuged. The residue containing muco-
proteins was discarded and the clear supernatant
stored at –20°C till assay.
Assay of salivary cortisol : The highest standard
(1935 nmol/l) provided in the Amerlex kit was
reconstituted in 500 µl of distilled water and
suitably diluted with 6 per cent human serum
albumin (HSA) in the assay buffer (0.1 M
phosphate buffer with 0.4 M sodium chloride
containing sodium azide lg/l and bovine serum
albumin lg/l – pH 7.4) to give standards ranging
from 20 to 968 nmol/l. The radioimmunoassay
control (C-15) was reconstituted in 1 ml of
distilled water and was used as ‘high’ control (362
nmol/l), and this was diluted 1 in 5 with 6 per cent
HSA in the assay buffer to give the ‘low’ control
(72.4 nmol/l). To 10 µl of the standards and
controls (as above) were added 100 µl of the assay
buffer to provide standard cortisol concentrations
of 2.0, 4.0, 8.0, 16.1, 32.2, 64.5 and 96.8 nmol/l
and control concentrations of 36.2 and 7.2 nmol/l
in a total volume of 110 µl. Ten µl of 6 per cent
HSA in the assay buffer was used in place of
cortisol solutions to provide the Zero standard.
The supernatants of the saliva samples were
processed at the same time and to 100 µl of these
samples were added 10 µl of 6 per cent HSA in the
assay buffer. To each of the above, set up in
duplicate, were added 50 µl of each of the 125I
tracer and the cortisol antibody suspension. The
contents were thoroughly mixed on a vortex
shaker and then incubated at 37°C for 3 h. They
were then centrifuged at 28°C at 1500 x g for 30
min, the supernatants discarded and. the precipitate
counted for 3 min in a Kontron automatic gamma
counter (Gammamatic II). A logit-log linear
regression curve-fit programme was employed for
the calculation of cortisol concentrations, the two
coordinates being the log concentrations of the
standards  (absc issa)  and the log i t  o f  the
percentage bound (ordinate).
Plasma cortisol was determined according to
the instructions of the manufacturers.
Precision of the method : To check the precision
of the salivary method, 3 controls were employed;
the radioimmunoassay control (C- 15) supplied by
Amersham was diluted 1 in 10 and 1 in 50, and
Wellcomtrol II of Wellcome Diagnostics was
diluted 1 in 10 with 6 per cent HSA in the assay
buffer. All three controls were set up in duplicate
on 16 different occasions (days) and the intra- and
inter-assay co-efficients of variation calculated.
Recovery of added cortisol : On each of 9
different occasions,cortisol concentrations of
12.5, 25.0 and 50.0 nmol/l were added to pooled
saliva. The assays were set up in duplicate and the
recoveries calculated.
Stability of cortisol : Cortisol concentrations in 40
samples of saliva collected during the tetracosactrin
timulation test were determined soon after
c llection and after storage at –20°C for 4
months.
Association between salivary cortisol and plasma
cortisol : The association was examined among 48
matched samples of plasma and saliva collected
during the tetracosactrin stimulation test. The
plasma ‘free’ cortisol fraction (unbound) was
separated from the bound cortisol by ultrafiltration
employing Centricon- microconcentrators of 2
ml capacity with a surface area of 0.92 cm2 of the
YM membrane (molecular weight cut-off: 10,000
daltons). Cortisol concentrations in plasma (total),
in the plasma ultrafiltrate (‘free’ fraction) and in
saliva were determined simultaneously, those in
the ultrafiltrate being determined by the same
procedure as that for salivary cortisol.
Subj cts : These investigations were undertaken in
sputum smear-positive patients with pulmonary
tub rculosis aged 20-59 yr and healthy subjects
aged 20-51 yr. For the tetracosactrin stimulation
test, wo groups of patients, one newly diagnosed
and the other, who had had the disease or been on
specific anti-tuberculosis treatment for more than
3 yr (chronic cases) were investigated. None of the
subjects was diabetic or pregnant and none was on
any form of steroid treatment at the time of
inv stigation. Informed consent was obtained
from the subjects and the study was cleared by the
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Ethical Committee of the Centre.
Diurnal variation of salivary cortisol : Sa iva was
collected at 0800 h and then at 2-hourly intervals
up to 2000 h from 7 newly diagnosed patients with
pulmonary tuberculosis and 6 healthy subjects.
Dexamethasone suppression test : Saliva was
collected between 0800 and 0830 h from 9 newly
diagnosed patients of pulmonary tuberculosis.
They were administered 1 mg dexamethasone
orally at bed time (2200 h) the same day, and
samples of saliva were collected again between
0800 and 0830 h the next morning.
ACTH stimulation test : The ACTH stimulation
test was performedmploying tetracosactrin,
which has a steroidogenic activity similar to the
natural corticotrophin.Saliva was collected
between 0800 and 0830 h from 36 healthy subjects,
27 newly diagnosed patients and 12 patients with
chronic pulmonary tuberculosis for the determina-
tion of basal cortisol levels and again at 1/2 h and
1 h after intramuscular administration of 0.25 mg
(about 24 units) of tetracosactrin. These subjects
were classified as positive or negative responders
to tetracosactrin on the basis of plasma cortisol
levels, the definition for a positive response being
an increase in plasma cortisol of 200 nmol/l or
more at 1/2 h and 1 h over the respective basal
levels12. Attempts were made to evolve criteria to
define a positive response to tetracosactrin on the
basis of increases in salivary cortisol and then to
validate these criteria in a fresh batch of 57 newly
diagnosed sputumsmear-positive patients of
pulmonary tuberculosis.
Student’s ‘t’ test (paired and unpaired) was
employed for testing the differences between the
mean cortisol levels, the Chi-square test with
Yates’ correction for continuity to test the
differences between the proportions, and the
analysis of variance (ANOVA) to examine the
precision of the method and also for testing the
differences between the mean cortigol concen-
trations in the study of the diurnal variation of
cortisol release. The sensitivity of the method was
calculated as described by Osredkar et al 13.
Tetracosactrin (synacthen) was gifted by Hindu-
stan Ciba Geigy Limited and cortisol assay kits
(Amerlex) were purchased from Amersham
International, England. Wellcomtrol II was
purchased from Wellcome Diagnostics, England.
Results
A typical standard curve (logit-log) for the
salivary cortisol estimation is depicted in Fig. 1.
The sensitivity of the method, defined as the
concentration of cortisol equivalent to 2 standard
deviations below the binding of the Zero
tandard13, was 0.8 nmol/ l. The binding of
labelled cortisol to the antiserum in the absence of
unlabelled cortisol (Zero standard) varied with the
total counts, and ranged between 41.1 to 53.1 per
cent during the course of these investigations. The
precision of the assay, as assessed by the intra-and
inter-assay co-efficients of variation together with
the expected and observed mean values are
presented in Table I. The variations observed are
typical of a steroid RIA. In practice, the tubes
were counted again or the assay repeated if the
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Fig. 1. Standard curve for assay of cortisol in saliva (vertical
bars indicate the standard deviation).
Table I. Precision of the salivary cortisol assay
Control
used
Expected Observed Co-efficient of
mean value mean variation (%)
and range value
(nmol/l) (nmol/l)
Intra- Inter-
assay assay
Amersham C-15 36.2 43.3 8.5 7.8
(1 in 10) (28.1-44.2)
Wellcomtrol II 27.3 24.8 10.5 13.3
(I in 10) (20.7-33.9)
Amersham C- I5 7.2 8.7 11.4 12.6
(1 in 50) (5.6-8.8)
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replicate variation in counts exceeded 10 per cent.
The mean cortisol value of pooled saliva used for
the recovery experiment was 12.8 ± 1.1 nmol/l.
The recoveries ranged from 83 to 124 per cent
(mean, 96%) when 12.5 nmol/l of cortisol was
added, from 73 to 105 per cent ((mean, 87%) with
25 nmol/l, and 66 to 95 per cent (mean, ‘80%)
following addition of 50 nmol/l. The mean
cortisol concentrations of 40 saliva samples before
and after storage for 4 months at –20°C were
34.7 ± 21.9 and 34.3 ± 24.1 nmol/l, respectively
(P > 0.2). The association between salivary
cortisol and plasma cortisol (total and ‘free’
fractions) was examined (Fig. 2). The correlation
co-efficients between salivary cortisol and the total
and ‘free’ fractions of plasma cortisol were 0.74
and 0.92, respectively (P < 0.001).
Diurnal variation of salivary cortisol : The mean
salivary concentrations of cortisol in the tuber-
culous patients were higher at all time-points than
the corresponding mean values in healthy subjects
(Fig. 3). In the healthy subjects, no significant
change was seen in salivary cortisol till 1200 h; a
decline was observed thereafter and the mean
values at 1600, 1800 and 2000 h were significantly
lower than that at 0800 h (P < 0.03). In the
patients, a slight increase was observed up to 1400
h followed by a decline and the mean values at
1600 and 1800 h were similar and lower than that
at 0800 h (P= 0.05, for both). However, there was
a rise thereafter and the mean value at 2000 h, was
higher than those at 1600 or 1800 h (P=0.01).
Dexamethasone suppression test : There was an
appreciable suppression (87%) of salivary cortisol
following administration of dexamethasone to
patients with pulmonary tuberculosis, the mean
salivary levels before and after dexamethasone
being 16.3 and 2.1 nmol/l, respectively (P <
0.001). The pre-and post-dexamethasone values
correlated well (r = 0.79; P= 0.01).
ACTH stimulation test : The mean salivary
concentrations of cortisol before (0 h) and at ½ h
and 1 h after stimulation with tetracosactrin are
presented in Table II. The mean basal saliva
concentration (0 h) in the newly diagnosed
patients was significantly higher than those in the
healthy subjects (P < 0.001) or the patients with
chronic TB (P=0.04). At ½ h and 1 h, the mean
concentration in the healthy subjects was similar
to that in the newly diagnosed patients; the mean
values in both these groups were, however,
significantly higher than that in the chronic TB
patients at both time-points (P < 0.01). The
association between base-line saliva levels and the
increases at ½ h and 1 h (amalgamating the
Table II. Salivary concentrations of cortisol before and after
stimulation with tetracosactrin
Mean (and range) cortisol concentrations in saliva (nmol/l)
Group (n) Basal value After tetracosactrin
(0 h) ½ h 1h
Healthy subjects (36) 9.2 37.4 53.9
(3.1-21.3) (15.8-57.7) (26.3-83.7)
Newly diagnosed 19.2 38.9 50.2
TB patients (27) (4.4-61.1) (16.2-80.2) (29.6-104.5)
Chronic 10.5 27.4 35.0
TB patients (12) (6.2-20.4) (18.6-40.6) (11.6-59.7)
Fig.2. Association between salivary cortisol and plasma total or plasma
‘free’ cortisol.
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Fig.3. Diurnal variation of salivary cortisol in healthy
and patients with pulmonary tuberculosis
Vertical bars indicate the standard error of the
mean.
findings in all 3 groups) was weak, the correlation
co-efficients being -0.37 at ½ h and -0.28 at 1 h.
The mean proportionate increases (%) over the
basal level following stimulation with tetracosactrin
in the 3 groups of subjects ranged from 163 to 394
per cent at ½ h and 254 to 617 per cent at 1 h. The
magnitude of increase in salivary cortisol was
significantly higher in the healthy subjects than in
either group of tuberculous patients (P < 0.001);
the differences between the two groups of patients
were, however, not significant (P > 0.2).
Classification as positive or negative responders to
tetracosactrin :Based on the increases in plasma
cortisol at ½ h and 1 h, 34 (94%) of 36 healthy
subjects, 13 (48%) of the 27 newly diagnosed
patients and 5 (42%) of the 12 chronic TB patients
had a positive response to tetracosactrin, the
difference in the proportions between the healthy
subjects and the 2 groups of patients being highly
significant (P < 0.001)12. Attempts were made to
derive suitable criteria to define a positive
response on the basis of both the absolute
increases and the proportionate increases in
cortisol levels in saliva at ½ h, 1 h or both over
the respective basal levels. Some of the criteria
that provided the best estimates for sensitivity and
specificity and agreement between the classifi-
cations based on the salivary and the plasma
methods are listed in Table III. The sensitivity of
the methods based on salivary concentrations
Table III. Estimates of sensitivity and specificity of salivary
estimation, and agreement between the salivary and the plasma
estimations in the classification of subjects as positive or
negative responders to tetracosactrin
Criterion Sensitivity Specificity Agreement
(%) (%) (%)
Based on absolute increase :
20 nmol/l or more at ½ h
30 nmol/l or more at 1 h
20 nmol/l or more at ½ h
and 1 h
75 70 73
79 83 80
75 78 76
Based on proportionate increase :
150% or more at ½ h 79
300% or more at 1 h 73
150% or more at ½ and 1 h 79
61 73
87 77
70 76
ranged from 73 to 79 per cent and the specificity
from 61 to 87 per cent; the agreement in the
classification between the two methods ranged
from 73 to 80 per cent with the different criteria.
Attempts were made to validate these criteria in
a fresh batch of 57 newly diagnosed patients of
pulmonary tuberculosis, 28 (49%) of whom were
classified as positive responders and the rest as
negative responders to tetracosactrin on the basis
of increases in plasma cortisol. The sensitivity of
the salivary method ranged from 46 to 68 per cent
and the specificity from 41 to 48 per cent when the
3 criteria based on absolute increases over the
b sal levels were employed. The estimates of
sensitivity and specificity were higher with the
criteria based on proportionate increases over the
basal levels, the sensitivity ranging from 61 to 68
per cent and the specificity from 72 to 86 per cent
for the 3 criteria listed.
Discussion
Determination of the low concentrations of
cortisol in saliva requires highly sensitive RIA
procedures, and most investigators have employed
‘in house’ reagents (antisera and labelled antigens)
for this purpose1-6. However, preparation of these
reagents is restricted to specialized laboratories,
and for routine use in clinical laboratories, it will
be desirable to adapt commercially available kits
designed for plasma/serum cortisol assays, for use
in saliva. Al-Ansari et al7 were the first to report
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such an adaptation using the Corning Immuno-
phase kit. We employed the ‘Amerlex’ kits and
slightly modified the procedure of Al-Ansari and
colleagues’, the modifications aimed at improving
the sensitivity of the method to provide a ‘Zero’
binding of approximately 50 per cent and to
ensure that the counts of the Zero standard were
at least 4 times higher than those with the highest
standard employed. The minimum detectable limit
was calculated to be 0.8 nmol/l as against 2.0
nmol/l reported by Al-Ansari et al7. With the
volumes of the reagents provided with the
‘Amerlex’ kit, it is possible to undertake 400
determinations in sal iva as against 100 in
plasma/ serum.The precision of our assay is
adequate, the variations observed being similar to
those reported by Vining et al5 and Al-Ansari et
al7. The findings of the recovery experiments,
however, suggest that it will be preferable to dilute
the saliva sample 1:1 with the assay buffer if the
cortisol concentrations exceed 50 nmol/l. Our
findings also suggest that cortisol concentrations
in saliva are stable for at least 4 months when
stored at–20ºC. According to information
provided with the Amerlex kit, the antiserum
supplied cross reacts strongly only with predniso-
lone (35%); the cross-reactivity with 24 other
steroid hormones and their metabolites was
negligible (< 2%). Since we used the same
antiserum,we did not undertake any further
studies on the specificity of the assay.
Stress induced by the disease is possibly
responsible for the substantially higher salivary
and plasma cortisol levels in newly diagnosed
patients with pulmonary tuberculosis than in
healthy subjects. The cortisol levels in chronic TB
patients are significantly lower than those in the
newly diagnosed patients, possibly due to the
infiltration of the adrenals by the tubercle bacilli.
The tetracosactrin stimulation test is employed
to examine the secretory potential of the adrenal
cortex, and accurately reflects the integrated
hypothalamic, pituitary and adrenal function14.
Similar to our observation with plasma levels12,
the rise in cortisol levels in saliva is much higher
in the healthy subjects than in the tuberculous
patients.A wide varietyof definitions are
available in the literature to define a normal
(positive) response to tetracosactrin based on the
increases in plasma cortisol levels12. However, to
the best of our knowledge, none is available to
define a positive response on the basis of salivary
cortisol. The increase in cortisol levels in saliva
was disproportionately higher than that in plasma
foll wing stimulation with tetracosactrin. Thus,
the mean increases in saliva in the 3 groups of
subj cts investigated ranged from 163 to 394 per
cent at ½ h and 254 to 614 per cent at 1 h; the
corresponding ranges in plasma were 49 to 115
and 64 to 148 per cent, respectively12. It is well
known15 that the binding sites of the cortisol-
binding protein, transcortin, get saturated when
plasma levels exceed 500 nmol/l. Thereafter, the
increased plasma cortisol would be redistributed
between the albumin-bound and ‘free’ fractions,
with a disproportionate increase in the plasma
‘free’ moiety, which would be reflected in the
sa ivary concentrations of the hormonex. Despite
the linear association between salivary cortisol
and plasma free cortisol, we did not succeed in
our attempts to derive criteria based on the
increase in the former (either absolute levels or
proportionate increases) for classification of
s bjects as positive or negativeresponders to
tetracosactrin in relation to the classification
based on plasma cortisol levels. The required
levels of sensitivity and specificity (> 90% for
both) were not attained and this was perhaps due
to inter-individual variation in plasma transcortin
concentrations. Peters et a116 have observed that it
is not possible to extrapolate normal ranges in
plasma to provide equivalent concentrations in
saliva in view of the inter-subject variation in the
plasma binding capacity and degree of saturation
of transcortin. However, in situations where the
saturation capacity of transcortin is not likely to
be exceeded, such as in the study of the diurnal
rhythm of cortisol secretion and the dexametha-
sone suppression test, changes in the salivary
lev ls can fairly reflect those observed in plasma.
In newly diagnosed patients of pulmonary
tuberculosis, dexamethasone caused a significant
suppression of salivary cortisol despite the high
circulating levels,a f inding similar to that
observed in plasma cortisol levels12. Thi  suggests
a normal activity of the pituitary in these patients.
The diurnal rhythm of cortisol secretion appears
to be disturbed in patients with tuberculosis with
an evening rise in salivary cortisol and this
phenomenon is similar to that reported earlier
with plasma levels12. High levels of cortisol in
saliva and a similar disturbed pattern were also
observed before start of treatment in a fresh batch
of 57 patients with pulmonary tuberculosis; the
levels and the pattern returned to normal after 2
months of treatment with effective regimens of
antituberculosis drugs (unpublished findings). The
reasons for the evening rise in cortisol levels in
these patients are not clear.
The findings reported here demonstrate that for
most tests of adrenocortical function, with the
exception of the tetracosactrin stimulation test,
salivary cortisol is as good a measure as plasma
cortisol and has the advantage of the collection
procedure being stress-free and non-invasive.
These findings and those reported earlier on
plasma levels 12 also suggest that adrenocortical
function is compromised in patients with pulmo-
nary tuberculosis. It will be worthwhile to study
the function of adrenal cortex in patients with
extra-pulmonary tuberculosis, particularly tuber-
culous meningitis and brain tuberculoma.
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